---
title: "Merck Announces Initial Access Plans For Alimatravir In Low- And Middle Income Countries"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293745407.md"
datetime: "2026-07-24T11:00:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293745407.md)
  - [en](https://longbridge.com/en/news/293745407.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293745407.md)
---

# Merck Announces Initial Access Plans For Alimatravir In Low- And Middle Income Countries

July 24 (Reuters) - Merck & Co Inc (MRK.N) : \* PLANS INITIAL ALIMATRAVIR SUPPLY PENDING REGULATORY APPROVAL, GENERIC MANUFACTURING RAMP-UP IN LICENSED TERRITORIES \* SIGNED NON-EXCLUSIVE VOLUNTARY LICENSING AGREEMENTS WITH ASPEN, QUALITY CHEMICAL INDUSTRIES & UCL KENYA FOR ALIMATRAVIR \* ANNOUNCES INITIAL ACCESS PLANS FOR ALIMATRAVIR IN LOW- AND MIDDLE INCOME COUNTRIES FOR PREVENTION OF HIV-1 \* IN ACTIVE DISCUSSIONS WITH FIOCRUZ ON ALIMATRAVIR AVAILABILITY IN LATIN AMERICA & BRAZIL

### Related Stocks

- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)

## Related News & Research

- [Aspen Pharmacare signs voluntary licensing deal with MSD for once-monthly HIV prevention pill MK-8527](https://longbridge.com/en/news/293755123.md)
- [Merck licenses experimental HIV pill to generic makers in 129 countries](https://longbridge.com/en/news/293743290.md)
- [Senate Democrats ask RFK Jr. if family will benefit from vaccine settlement](https://longbridge.com/en/news/294239804.md)
- [GSK Races To Protect Profits Before Its HIV Blockbuster Faces Generic Rivals](https://longbridge.com/en/news/294098349.md)
- [Is Merck’s Expanding Oncology, Vaccine and HIV Portfolio Altering The Investment Case For Merck (MRK)?](https://longbridge.com/en/news/291600395.md)